Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry

被引:7
|
作者
Tigre, Paulo Bastos [1 ]
Machado Franca do Nascimento, Caio Victor [1 ]
Costa, Lais Silveira [2 ]
机构
[1] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil
[2] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil
来源
CADERNOS DE SAUDE PUBLICA | 2016年 / 32卷
关键词
Drug Industry; Generic Drugs; Sustainable Development; Innovation; BIOSIMILARS; HEALTH; PERFORMANCE; DRUGS;
D O I
10.1590/0102-311X00103315
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The Brazilian pharmaceutical industry is heavily dependent on external sources of inputs, capital, and technology. However, the emergence of technological opportunities and the development of biotechnology and the decline of the patent boom and resulting advances by generic drugs have opened windows of opportunities for the local industry. The article examines the Brazilian industry's innovative behavior vis-a-vis these opportunities, showing that although the industry as a whole invests little in innovation, a few large Brazilian companies have expanded their market share and stepped up their investments in research and development, supported by public policies for innovation.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Organizing for technological innovation in the US pharmaceutical industry
    Chacar, AS
    Lieberman, MB
    [J]. GEOGRAPHY AND STRATEGY, 2003, 20 : 317 - 340
  • [2] The dynamics of technological innovation: the case of the pharmaceutical industry
    Achilladelis, B
    Antonakis, N
    [J]. RESEARCH POLICY, 2001, 30 (04) : 535 - 588
  • [3] The diffusion of technological innovation in the Brazilian ethanol industry
    Camargo Junior, Alceu Salles
    Yu, Abraham Sin Oih
    Nascimento, Paulo Tromboni de S.
    Santos, Gilberto Martins
    [J]. PICMET '12: PROCEEDINGS - TECHNOLOGY MANAGEMENT FOR EMERGING TECHNOLOGIES, 2012, : 2055 - 2071
  • [4] Determinants of pharmaceutical innovation: the role of technological opportunities revisited
    Bastian Rake
    [J]. Journal of Evolutionary Economics, 2017, 27 : 691 - 727
  • [5] Determinants of pharmaceutical innovation: the role of technological opportunities revisited
    Rake, Bastian
    [J]. JOURNAL OF EVOLUTIONARY ECONOMICS, 2017, 27 (04) : 691 - 727
  • [6] THE DYNAMICS OF TECHNOLOGICAL INNOVATION: THE ROLE OF DEMAND-PULL, TECHNOLOGICAL-PUSH AND GOVERNMENT INCENTIVES IN THE BRAZILIAN PHARMACEUTICAL INDUSTRY
    Pereira da Veiga, Cassia Rita
    da Veiga, Claudimar Pereira
    Del Corso, Jansen Maia
    da Silva, Wesley Vieira
    [J]. REGE-REVISTA DE GESTAO, 2012, 19 (04): : 515 - 534
  • [7] Innovation on Expired Patent Medicines in the Brazilian Pharmaceutical Industry
    Yugue, R. T.
    Maximiano, A. C. A.
    Sbragia, R.
    Nascimento, P. T. S.
    [J]. 2018 PORTLAND INTERNATIONAL CONFERENCE ON MANAGEMENT OF ENGINEERING AND TECHNOLOGY (PICMET '18): MANAGING TECHNOLOGICAL ENTREPRENEURSHIP: THE ENGINE FOR ECONOMIC GROWTH, 2018,
  • [8] Is industry-university interaction promoting innovation in the Brazilian pharmaceutical industry?
    Paranhos, Julia
    Hasenclever, Lia
    [J]. INDUSTRY AND HIGHER EDUCATION, 2011, 25 (05) : 397 - 407
  • [9] Innovation strategy management survey of the Chilean biomedical industry. Assessment of windows of opportunities to reduce technological gaps
    Bas, Tomas Gabriel
    Oliu, Carolina Alejandra
    [J]. INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT, 2018, 33 (02): : E512 - E530
  • [10] Technological innovation in Brazilian industry: An assessment based on the Sao Paulo innovation survey
    Quadros, R
    Furtado, A
    Bernardes, R
    Franco, E
    [J]. TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE, 2001, 67 (2-3) : 203 - 219